UNSPSC 51334100: Antipsychotic thiazoles

Antipsychotic drugs made from sulfur compounds with nitrogen, based on C3H3NS.

UNSPSC 51334100 Antipsychotic thiazoles is a Class code that appears to see little activity aligned with its nominal pharmaceutical scope in recent state and local solicitations. The three opportunities posted in the past six months—a Seminole County naloxone and drug deactivation systems procurement, a Texas HHS Commission Request for Information on direct-to-manufacturer prescriptions, and a Minnesota Multistate Cooperative Purchasing Alliance RFP for generic multi-source pharmaceuticals and OTC products—do not target antipsychotic thiazoles specifically. The Seminole County and Texas HHS opportunities address emergency response and pharmacy benefit management respectively, while the MMCAP RFP seeks broad generic pharmaceutical supply across multiple therapeutic classes without emphasis on antipsychotics. When state and local governments procure pharmaceuticals under this code, they typically do so through cooperative purchasing vehicles and fixed-price supply agreements with authorized wholesalers, requiring compliance with cGMP, DSCSA, FDA requirements, and substantial insurance coverage.

Issuing bodies include state health agencies, county health departments, and multistate cooperative purchasing alliances serving both state and local government members across multiple jurisdictions. Recent activity centers on Florida and Minnesota, with participation from Oregon through MMCAP, though the code shows no evidence of concentrated repeat buying or a defined geographic cluster. The MMCAP RFP issued by the Minnesota Department of Administration in January 2026 with a March 26, 2026 response deadline represents the most formal opportunity, establishing contracts effective July 1, 2026 and evaluated 75 percent on price competitiveness; the Seminole County IFB for naloxone and drug deactivation systems closed July 26, 2023 and does not reflect current antipsychotic-specific demand. The mismatch between the code's nominal scope and the pharmaceutical opportunities actually being solicited suggests that state and local antipsychotic procurement may be bundled into broader pharmaceutical contracts or tagged to alternative codes, making this code a lower-priority monitoring target for firms specializing in antipsychotic supply.